$MRNA Soars 150% in Best Day Ever After Cancer Vaccine Shows Promise Against Melanoma Recurrence

Moderna shares surged 150% on their best trading day in company history after a cancer vaccine demonstrated potential in preventing the recurrence of melanoma.